Show simple item record

dc.date.accessioned2015-08-25T14:54:25Z
dc.date.available2015-08-25T14:54:25Z
dc.date.issued1999es
dc.identifier.citation(1999) Programa de detección de fallas de calidad en los medicamentos comercializados. Rev Panam Salud Publica;6(3) -,sept. 1999. Retrieved from http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891999000800014&lng=pt&nrm=isoes
dc.identifier.urihttp://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891999000800014&lng=pt&nrm=isoes
dc.identifier.urihttp://iris.paho.org/xmlui/handle/123456789/8897
dc.format.extentiluses
dc.format.extenttabes
dc.relation.ispartofseriesRev Panam Salud Publica;6(3),sept. 1999es
dc.subjectQualidade dos Medicamentos Homeopáticoses
dc.subjectDeterminaçãoes
dc.subjectVigilância de Produtos Comercializadoses
dc.titlePrograma de detección de fallas de calidad en los medicamentos comercializadoses
dc.title.alternativeA program to detect defective drugs in the postmarketing periodes
dc.typeJournal Articlees
dc.description.notesDefective drugs have been found during the postmarketing phase in various countries, regardless of those nations' level of economic development. This paper proposes guidelines for a program to uncover drug defects in the postmarketing surveillance period. Such a program should be run by a center or service organized for that purpose within the framework of a national drug surveillance systemes


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record